BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Baker Bros. Advisors LP bought $2.5M of BioCryst Pharmaceuticals, Inc.
10% owner
Bought$2,510,143
$7.28Price
344,895Shares
+1%Stake
What BCRX did for a copier
Prices for BCRX after this filing aren't in yet.
Baker Bros. Advisors LP's record
22 other buys with 3 months of prices since 2016: on average +13.8% against the S&P 500, and 12 of 22 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jan 15. Filed Wed, Jan 20. Not investment advice.